Vitro Biopharma, Inc.

CIK 793171 · 369 filings in 38 form types · 1996-10-23 to 2026-09-18

Former names: VITRO DIAGNOSTICS INC

FiledFormCategory8-K items / descriptionAccession
2026-09-18 10-Q Financial reports 10-Q 0001493152-26-043284
2026-09-14 NT 10-Q Financial reports 0001493152-26-042532
2026-06-15 10-Q Financial reports 10-Q 0001493152-26-028655
2026-03-16 10-Q Financial reports 10-Q 0001493152-26-010236
2026-02-13 10-K Financial reports 10-K 0001493152-26-006592
2026-01-29 NT 10-K Financial reports 0001493152-26-004145
2025-09-12 10-Q Financial reports 10-Q 0001641172-25-027168
2025-06-20 10-Q Financial reports 10-Q 0001641172-25-015758
2025-06-16 NT 10-Q Financial reports 0001641172-25-015274
2025-06-11 D Other 0001641172-25-014683
2025-03-20 10-Q Financial reports 0001493152-25-011003
2025-03-17 NT 10-Q Financial reports 0001493152-25-010585
2025-01-28 10-K Financial reports 0001493152-25-003942
2024-09-16 10-Q Financial reports 0001493152-24-036326
2024-09-11 EFFECT Registrations and prospectuses 9999999995-24-002788
2024-09-10 CORRESP Other 0001493152-24-035690
2024-09-10 CORRESP Other 0001493152-24-035688
2024-09-05 S-1/A Registrations and prospectuses 0001493152-24-035112
2024-08-29 CORRESP Other 0001493152-24-034388
2024-08-29 UPLOAD Other 0000000000-24-009860
2024-08-23 CORRESP Other 0001493152-24-033733
2024-08-23 S-1/A Registrations and prospectuses 0001493152-24-033726
2024-08-20 UPLOAD Other 0000000000-24-009520
2024-08-08 CORRESP Other 0001493152-24-030729
2024-08-08 S-1/A Registrations and prospectuses 0001493152-24-030726
2024-07-26 UPLOAD Other 0000000000-24-008504
2024-07-22 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-24-028669
2024-07-01 CORRESP Other 0001493152-24-025755
2024-07-01 S-1/A Registrations and prospectuses 0001493152-24-025754
2024-06-27 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-24-025334
2024-05-31 10-Q Financial reports 0001493152-24-022030
2024-05-17 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-24-020410
2024-04-17 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-24-015061
2024-03-14 10-Q Financial reports 0001493152-24-009929
2024-02-21 UPLOAD Other 0000000000-24-001960
2024-02-02 CORRESP Other 0001493152-24-004780
2024-02-02 S-1/A Registrations and prospectuses 0001493152-24-004779
2024-01-29 10-K Financial reports 0001493152-24-004126
2024-01-23 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001493152-24-003346
2024-01-16 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-24-002272
2024-01-11 UPLOAD Other 0000000000-24-000414
2023-12-12 S-1/A Registrations and prospectuses 0001493152-23-044572
2023-12-01 D Other 0001876512-23-000002
2023-11-22 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits 0001493152-23-042449
2023-09-12 CORRESP Other 0001493152-23-032370
2023-09-12 CORRESP Other 0001493152-23-032369
2023-09-08 CORRESP Other 0001493152-23-032102
2023-09-08 CORRESP Other 0001493152-23-032099
2023-08-29 S-1/A Registrations and prospectuses 0001493152-23-030408
2023-08-28 CORRESP Other 0001493152-23-030409